herzuma
(TRASTUZUMAB)Cephalon, Inc.
Usage: HERZUMA is indicated for adults with HER2 overexpressing breast cancer, both in adjuvant and metastatic settings, and for metastatic gastric or gastroesophageal junction adenocarcinoma. Treatment modalities include combinations with specific chemotherapies or as a single agent, guided by FDA-approved diagnostics.